Why it was recalled
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Product description
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
Lot numbers, UPCs & expiration codes
Lot #: 1MP24042, Exp 6/30/26
Where it was sold
Distributed to Medical Facilities in MS and FL.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0400-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Apr 25, 2025
- FDA report date
- May 7, 2025
- Quantity
- 3
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
Original FDA data
Every field from FDA enforcement report D-0400-2025, exactly as published.
Show all FDA fields
- City
- Richmond
- State
- VA
- Status
- Ongoing
- Country
- United States
- Event ID
- 96744
- Address
- 9954 Maryland Drive
- Address (line 2)
- Deep Run Iii Ste. 4000
- Code information
- Lot #: 1MP24042, Exp 6/30/26
- Postal code
- 23233
- Report date
- May 7, 2025
- Product type
- Drugs
- Recall number
- D-0400-2025
- Classification
- Class II
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Product quantity
- 3
- Reason for recall
- Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
- Distribution pattern
- Distributed to Medical Facilities in MS and FL.
- Recall initiation date
- Apr 25, 2025
- Center classification date
- May 1, 2025